Scientists say the drug stops the virus from replicating inside cells. The landmark deal to provide cheaper antiretroviral ...

A total of 10 individuals with HIV have been cured to date. Most of these patients have remained anonymous, but three have ...

A twice-yearly injection described as the most promising HIV prevention tool in decades is poised to reach millions more ...

A groundbreaking discovery reveals how HIV integrates its genetic material into human DNA, exposing a key viral vulnerability ...

This antiretroviral has shown unprecedented results in HIV prevention, requiring only two injections per year. Its ...

The CDC made a strong recommendation based on a high certainty of evidence to use the long-acting injectable lenacapavir ...

Global health groups will provide backing for two generic manufacturers to produce and distribute a low-cost version of a new ...

Yeztugo (lenacapavir) is an HIV-1 capsid inhibitor that is administered every 6 months after an initial dosing regimen.

Indian drugmakers Dr Reddy's Laboratories and Hetero Labs said on Wednesday that they will sell generic versions of a new and ...

As HIV diagnoses continue increasing in metro Atlanta, the number of dollars for research and treatment is going down.

Patients visiting emergency departments in the Humber region will be tested for serious infections under a new initiative.

Two partnerships will provide millions of people access to what is widely described as the most effective HIV prevention drug ...